Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy

•dNLR is a prognostic biomarker irrespective of the first-line systemic therapy.•Features from lymphoid tissues on [18F]-FDG-PET/CT are also prognostic biomarkers.•Spleen glucose metabolism (SLR) correlates with outcome after immunotherapy (IT).•Bone marrow glucose metabolism (BLR) correlates with o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lung cancer (Amsterdam, Netherlands) Netherlands), 2021-09, Vol.159, p.45-55
Hauptverfasser: Seban, Romain-David, Assié, Jean-Baptiste, Giroux-Leprieur, Etienne, Massiani, Marie-Ange, Bonardel, Gérald, Chouaid, Christos, Deleval, Nicolas, Richard, Capucine, Mezquita, Laura, Girard, Nicolas, Champion, Laurence
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•dNLR is a prognostic biomarker irrespective of the first-line systemic therapy.•Features from lymphoid tissues on [18F]-FDG-PET/CT are also prognostic biomarkers.•Spleen glucose metabolism (SLR) correlates with outcome after immunotherapy (IT).•Bone marrow glucose metabolism (BLR) correlates with outcome after chemotherapy (CT).•Patients with high dNLR and SLR have a major risk of progression on IT, but not on CT. We aimed to compare the prognostic value of inflammatory biomarkers extracted from pretreatment peripheral blood and [18F]-FDG PET for estimating outcomes in non-small cell lung cancer (NSCLC) patients treated with first-line immunotherapy (IT) or chemotherapy (CT). In this retrospective multicenter study, we evaluated 111 patients with advanced NSCLC who underwent baseline [18F]-FDG PET/CT before IT or CT between 2016 and 2019. Several blood inflammatory indices were evaluated: derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), C-reactive protein (CRP) and systemic immune-inflammation index (SII). FDG-PET inflammatory parameters were extracted from lymphoid tissues (BLR and SLR: bone marrow or spleen-to-Liver SUVmax ratios). Association with survival and relationships between parameters were evaluated using Cox prediction models and Spearman's correlation respectively. Overall, 90 patients were included (IT:CT) (51:39pts). Median PFS was 8.6:6.6 months and median OS was not reached:21.2 months. In the IT cohort, high dNLR (>3), high SII (≥1,270) and high SLR (0.77) were independent statistically significant prognostic factors for one-year progression-free survival (1y-PFS) and two-year overall survival (2y-OS) on multivariable analysis. In the CT cohort, high BLR (≥0.80) and high dNLR (>3) were associated with shorter 1y-PFS (HR 2.2, 95% CI 1.0–4.9) and 2y-OS (HR 3.4, 95CI 1.1–10.3) respectively, on multivariable analysis. Finally, BLR significantly but moderately correlated with most blood-based inflammatory indices (CRP, PLR and SII) while SLR was only associated with CRP (p 
ISSN:0169-5002
1872-8332
DOI:10.1016/j.lungcan.2021.06.024